-
Jun 23, 2016, 12:45 PM
by
Michael Croft
Computerworld | Three vendors, including Microsoft and Amazon Web Services, have won a key U.S. government authorization that will allow federal agencies to put highly sensitive data on the cloud-computing services.
Full story
-
Jun 23, 2016, 09:27 AM
by
Michael Croft
Computerworld | Intel, SAP, Lyft, Spotify and VMware are among more than 30 Silicon Valley companies to sign a pledge that they would take action to make their technology workforce "fully representative of the American people, as soon as possible."
Full story
-
Jun 23, 2016, 08:17 AM
by
Michael Croft
PRINCETON, NJ - Jun 23, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the availability of D360 Express
Full story
-
Jun 22, 2016, 10:44 AM
by
Michael Croft
Computerworld | As the head of Amazon Web Services, Andy Jassy has seen a lot of big organizations start using the public cloud. The biggest indicator of success for a cloud transition is simple, he says: Has the business' senior staff bought into it?
Full story
-
Jun 22, 2016, 09:47 AM
by
Michael Croft
PRINCETON, NJ - Jun 22, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information, and the addition of Kenneth A
Full story
-
Jun 22, 2016, 06:33 AM
by
Michael Croft
JORDBRO, SWEDEN - Jun 22, 2016 - RECIPHARM, the contract development and manufacturing organisation (CDMO), has formed a global partnership with Marchesini, SEA Vision and TraceLink to introduce new serialisation capabilitiesx
Full story
-
Jun 22, 2016, 05:45 AM
by
Michael Croft
CAMBRIDGE, UNITED KINGDOM - Jun 22, 2016 - In about 3% of pregnancies a fetal anomaly is detected by ultrasound; knowing the cause would greatly assist an accurate diagnosis and provide information about the potential health implications
Full story
-
Jun 21, 2016, 16:44 PM
by
Michael Croft
Xconomy | Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with the CRISPR-Cas9 clinical trial.
Full story
-
Jun 21, 2016, 15:56 PM
by
Michael Croft
ANDOVER, MA, UNITED STATES - Jun 21, 2016 - June 21, 2016 Philipsexpands its Digital Pathology Solutions portfolio with the acquisition of PathXL Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has acquired PathXL, a Northern Ireland-based leader in digital pathology image analysis, workflow software and educational tools
Full story
-
Jun 21, 2016, 13:16 PM
by
Michael Croft
The San Diego Union-Tribune | Illumina's Flatley speaks of genomic future. Longtime CEO stepping down to become chairman, looks for near-universal use of genome sequencing.
Full story
-
Jun 21, 2016, 13:15 PM
by
Michael Croft
NEW YORK, NY, UNITED STATES - Jun 21, 2016 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and the Southampton Clinical Trials Unitat the University of Southampton today announced a partnership to accelerate drug development across the United Kingdom
Full story
-
Jun 21, 2016, 11:31 AM
by
Michael Croft
NOTTINGHAM, UNITED KINGDOM - Jun 21, 2016 - Nottingham, UK – Juniper Pharma Services (the company), a subsidiary of Juniper Pharmaceuticals, Inc
Full story
-
Jun 20, 2016, 14:16 PM
by
Michael Croft
Receives prestigious When Work Works Award for the fourth time Chapel Hill, NC (June 15, 2016) – Rho, a full service contract research organization (CRO) focused on bringing new products to market through a full
Full story
-
Jun 20, 2016, 12:43 PM
by
Michael Croft
Computerworld | Some of the world's fastest computers use Nvidia's graphics processor for computer vision and complex calculations, and a new GPU will supercharge these applications.
Full story
-
Jun 20, 2016, 09:40 AM
by
Michael Croft
MUNICH, GERMANY - Jun 20, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced that chief commercial officer Merrilyn Datta, PhD, will present at Rational Combinations 360°, being held in New York, NY from June 23-24, 2016
Full story
-
Jun 17, 2016, 12:07 PM
by
Michael Croft
PHILADELPHIA, PA, USA - Jun 17, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that WuXi AppTec, the world's largest Contract Research Outsourcing (CRO) provider, has adopted Reaxys® and Reaxys® Medicinal Chemistry
Full story
-
Jun 17, 2016, 10:40 AM
by
Michael Croft
Bio-IT World | Best Practices Winner | Despite advances in genomics in the past decade, there are still large portions of the genome that scientists and physicians don’t know how to interpret. Human Longevity Inc. (HLI) wants to fill in those gaps.
Full story
-
Jun 17, 2016, 09:45 AM
by
Michael Croft
Computerworld | China's Tianhe-3 exascale system is set to go live in 2020, three years ahead of the US roadmap. But raw power aside, what might matter most in next-gen systems is how efficiently apps run.
Full story
-
Jun 15, 2016, 16:25 PM
by
Michael Croft
Bio-IT World Rgenix, a cancer therapeutics company developing first-in-class drugs targeting novel cancer pathways, announced a $33 million Series B financing led by Novo A/S and Sofinnova Partners, with participation from existing investors including Partnership Fund for New York City, Alexandria Venture Investments, and Conegliano Ventures LP. The financing will support clinical development of Rgenix’s lead drug candidates, RGX-104 and RGX-202, as well as further development of its therapeutics pipeline.
Full story
-
Jun 15, 2016, 11:50 AM
by
Michael Croft
Bio-IT World The National Cancer Institute's new Genomic Data Commons platform aims to make genomic data publicly available in support of the “moonshot” to cure cancer.
Full story